Daily SPAC Update – September 10, 2024

by | Sep 10, 2024

AVHI + Vaso Corp Merger Vote. GATE Extension Vote. ROSS and TMTC Set Extension Vote Dates.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

MERGER VOTES
AVHI + VASO CORP

EXTENSION VOTES
GATE – MARBLEGATE ACQUISITION CORP * vote Sept 10, 2024 -> extend from October 5, 2024 to April 5, 2025

SPAC DEAL & EXTENSION VOTES SET
ROSS – Ross Acquisition Corp Ii * EXTENSION VOTE SET: Sep 16, 2024 * trust $11.43
TMTC – Tmt Acquisition Corp * EXTENSION VOTE SET: Sep 24, 2024 * trust $11.15

OTHER SPAC NEWS
LATG – CHENGHE ACQUISITION I CO * Merger Agreement Amendment

SEPARATE WARRANTS/RIGHTS
GIG on Sep 10

SPAC LIQUIDATIONS
TortoiseEcofin Acquisition Corp. III (TRTLF)-> Liquidation on Sep 06

YESTERDAY’S TOP SPAC GAINERS
9.29% ~ $ 10.00 | PTWO – Pono Capital Two, Inc. (Announced)
3.13% ~ $ 12.86 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)
2.95% ~ $ 11.50 | SEDA – SDCL EDGE Acquisition Corp (Pre-Deal)
2.54% ~ $ 12.51 | NPAB – New Providence Acquisition Corp. II (Pre-Deal)
1.93% ~ $ 11.62 | QOMO – Qomolangma Acquisition Corp. (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-4.89% ~ $ 10.51 | IRAA – Tribe Capital Growth Corp I (Announced)
-3.35% ~ $ 11.68 | CLOE – Clover Leaf Capital Corp. (Announced)
-1.55% ~ $ 11.07 | FIAC – Focus Impact Acquisition Corp. (Announced)
-.90% ~ $ 11.00 | FTII – Future Tech II Acquisition Corp. (Pre-Deal)
-.86% ~ $ 11.50 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)

LATEST SPAC IPO PERFORMANCE
Sep 06 | $ 9.98 | VCIC – Vine Hill Capital Investment Corp.
Sep 06 | $ 9.98 | POLE – Andretti Acquisition Corp. II
Aug 29 | $ 9.96 | GIG – GigCapital7 Corp.
Aug 28 | $ 9.97 | BSII – Black Spade Acquisition II Co
Aug 16 | $ 10.00 | HOND – HCM II Acquisition Corp.
Aug 16 | $ 10.01 | SBXD – SilverBox Corp IV

Recent Analysis

Weekly Boardroom & Executive Moves: May 1, 2026

This week, significant leadership changes occurred across several companies facing financial difficulties. Abbott Laboratories (ABT) and Agilon Health Inc (AGL) appointed new board members and executives amidst high activist risks and declining TSRs. Accuray Inc (ARAY) and ALT5 Sigma Corp (ALTS) also saw key executive departures and appointments as they navigate substantial TSR declines. These shifts highlight the ongoing challenges and strategic redirections needed to stabilize operations and improve shareholder value.

Daily SPAC Update – May 1, 2026

Two SPAC IPOs launched today, raising a total of $500 million. CH4 Natural Solutions Acquisition Corp (MTNE) secured $300 million, while Quantum Leap Acquisition Corp (QLEP) raised $200 million. Today, 2 SPAC IPOs raised $500M, led by CH4 Natural Solutions (MTNE) at $300M. This follows a surge of activity at the end of April.

Daily SPAC Update – April 30, 2026

Today, six SPACs debuted, raising a total of $965 million. General Catalyst Global Resilience Merger Corp (GCGR) led the pack with $350 million, followed by RRE Ventures Acquisition Corp. (RREV) at $250 million. Month-to-date, SPAC IPOs total 16, bringing in $2.65 billion, compared to 11 IPOs last month that raised $1.72 billion.

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.